- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SAGE
Recent news which mentions SAGE
56 Biggest Movers From Yesterday
February 17, 2022
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 16, 2022
From Benzinga
Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
February 16, 2022
From Benzinga
From InvestorPlace
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
New Psychedelics ETF Launches On NYSE Arca
February 02, 2022
From Benzinga
Where Will Biogen Be in 5 Years?
January 15, 2022
From Motley Fool
Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S.
December 28, 2021
From Benzinga
5 Value Stocks In The Healthcare Sector
December 27, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
December 06, 2021
From Benzinga
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
December 01, 2021
From Benzinga
From Benzinga
These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
November 29, 2021
From MarketWatch
Is Compass Pathways Stock a Once-in-a-Lifetime Bargain?
November 11, 2021
From Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
November 08, 2021
From Benzinga
What 8 Analyst Ratings Have To Say About Sage Therapeutics
November 03, 2021
Tickers
SAGE
From Benzinga
10 Biggest Price Target Changes For Wednesday
November 03, 2021
From Benzinga
Sage Therapeutics Inc (SAGE) Q3 2021 Earnings Call Transcript
November 02, 2021
Tickers
SAGE
From Motley Fool
How Bad Are Sage Therapeutics's Earnings? | Return On Capital Employed
November 02, 2021
Tickers
SAGE
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
Should Biogen Investors Be Preparing for the Worst?
October 27, 2021
From Motley Fool
3 Big Problems With Biogen's Q3 Results
October 23, 2021
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.